These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 222484)

  • 1. Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid.
    Glaser M; Lotan R
    Cell Immunol; 1979 Jun; 45(1):175-81. PubMed ID: 222484
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
    Glaser M
    Cell Immunol; 1979 Dec; 48(2):339-45. PubMed ID: 228870
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaboration between distinct subpopulations of T cells in in vitro generation of effector cells capable of growth prevention of syngeneic SV40-induced sarcoma in mice.
    Glaser M
    Cell Immunol; 1979 Nov; 48(1):71-8. PubMed ID: 228868
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of retinoic acid on the immune system: stimulation of T killer cell induction.
    Dennert G; Lotan R
    Eur J Immunol; 1978 Jan; 8(1):23-9. PubMed ID: 346357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
    Law LW; Takemoto KK; Rogers MJ; Ting RC
    J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the cellular immune response to simian virus 40 tumor cells in tumor-bearing and tumor-immune mice by concanavalin A.
    Davis S; Boone CW
    J Natl Cancer Inst; 1975 Feb; 54(2):435-8. PubMed ID: 163333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion paper: specific paralysis of the antitumor cellular immune response produced by growing tumors studied with a radioisotope footpad assay.
    Paranjpe MS; Boone CW; Takeichi N
    Ann N Y Acad Sci; 1976; 276():254-9. PubMed ID: 194516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunostimulation of the growth of a syngeneic sarcoma primarily induced in mice by simian adenovirus SA7(C8)].
    Ageenko AI; Erkhov VS
    Vopr Onkol; 1977; 23(8):57-60. PubMed ID: 906408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
    Plata R; MacDonald HR; Engers HD
    J Immunol; 1976 Jul; 117(1):52-8. PubMed ID: 180182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT; MacDonald HR; Cerottini JC
    J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract]   [Full Text] [Related]  

  • 19. T-T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice.
    Glasser M; Law LW
    Nature; 1978 Jun; 273(5661):385-7. PubMed ID: 207992
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
    Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
    J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.